Anika Therapeutics | ANIK - Market Capitalization


Anika Therapeutics reported $216.4M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Agenus USD 107M 16M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Integra LifeSciences USD 967M 150M Dec/2025
J&J USD 578.59B 562M Apr/2026
Karyopharm Therapeutics USD 652M 517M Apr/2026
MacroGenics USD 102M 4M Dec/2025
Merit Medical Systems USD 5.23B 297M Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Smith & Nephew USD 3.77B 9.55B Apr/2026
Stryker USD 134.41B 6.92B Dec/2025
Veracyte USD 3.33B 627M Dec/2025
Xencor USD 1.09B 256M Dec/2025
Zimmer Biomet Holdings USD 17.82B 1.69B Dec/2025